16:00 Comparing Novos Triple to Retatrutide Analysis of weight loss percentages versus Lillys retatrutide data and the caution required when comparing across trials
Although clinically effective, they are associated with significant metabolic side effects, including increased insulin resistance, impaired function of pancreatic -cells, and, finally, weight gain
According to a recent report by Morgan Stanley, the global market for obesity drugs is expected to increase 15-fold by 2030, driven by their expanding use beyond weight loss to address various obesity-related conditions
Libido: moving in both directions 35% reported no change 29% reported higher libido 19% reported lower libido Body confidence and sex life 70% of women reported improvements in body confidence and sex life Mood and lifestyle changes 45% said their mood became more stable 53% lost interest in foods they previously enjoyed 49% reported reduced desire to drink alcohol What this tells us GLP-1 may influence behavior, emotional state, habits